At December 31, 2024, the Company's cash and cash equivalents grew to $912.8 million, compared to $713.7 million at December 31, 2023, which accounts for approximately $100.0 million of repurchased ...
Initiated the Phase 3 VELA program of the Nanobody ® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa ...
Cybercriminals are exploiting GitHub to spread credential-stealing malware through fake repositories, cybersecurity firm ...
Project 2025, a conservative playbook by the Heritage Foundation, is influencing significant changes in U.S. health policy ...
The Utilities Regulation and Competition Authority (URCA) has engaged a firm to conduct a survey on the state of access and use of information and communications technology throughout The Bahamas.
EML’s balance sheet is showing recovery from prior stretched levels. December 2024's gearing (interest-bearing borrowings/equity) ratio sits at 29%, up from 57% in June 2024 and 56% in June 2023. Net ...